The effect of primary hyperparathyroidism on pancreatic exocrine function

Area of Science:

• Endocrinology
• Gastroenterology
• Biochemistry

Background:

• Elastase-1 is a pancreatic enzyme crucial for assessing exocrine function.
• Chronic hypercalcemia is a condition associated with primary hyperparathyroidism.
• The potential link between hypercalcemia and pancreatic dysfunction requires investigation.

Purpose of the Study:

• To investigate if chronic hypercalcemia, as seen in primary hyperparathyroidism, leads to a decline in pancreatic exocrine function.
• To evaluate pancreatic exocrine function by measuring fecal elastase levels in patients with primary hyperparathyroidism.

Main Methods:

• A cohort of 75 patients with primary hyperparathyroidism (PHPT) and 30 healthy controls were enrolled.
• Fecal elastase concentrations were measured, alongside various biochemical and bone density parameters.
• Comprehensive health assessments included renal function, lipid profiles, and hormone levels.

Main Results:

• Mean fecal elastase levels were 335.3 ± 181.4 μg/g in the PHPT group and 317.4 ± 157.3 μg/g in the control group.
• No statistically significant difference in fecal elastase levels was observed between the PHPT group and the control group (p = 0.5).

Conclusions:

• Chronic hypercalcemia in primary hyperparathyroidism does not appear to reduce fecal elastase levels.
• These findings suggest that chronic hypercalcemia may not be a direct cause of chronic pancreatitis.
• Pancreatic exocrine function remains preserved in the context of primary hyperparathyroidism-induced hypercalcemia.